Jump to content
PathLabTalk

DebbieL

Members
  • Content Count

    101
  • Joined

  • Last visited

  • Days Won

    6
  • Country

    United States

DebbieL last won the day on June 22 2017

DebbieL had the most liked content!

About DebbieL

  • Rank
    Junior Member
  • Birthday 08/30/1955

Recent Profile Visitors

1,481 profile views
  1. I searched the operator's manual for info and also contacted Immucor about carryover. They basically said there could be carryover but it would be extremely rare since the patient's titer would have to be higher than 5120 and humans do not reach that level. So I decided to use the CAP JAT or J series and test 2 or up to 5 in the same run. The positives are generally pretty strong (4+) and there is always at least 1 negative in the bunch. I also look thru the past patient testing and find at least 3 strong positive (3-4+) patients with either a negative patient in the same run or the next
  2. Brenda, So glad you gave some possibilities about how to QC an expired panel. We actually have been doing something similar for several years. In your example, when we needed to use an expired panel to rule out E we would use the patient's plasma with a Jka+E= panel cell to prove the panel would detect the antibody we suspected as proof it was viable to use. Looks like it would be just as easy to use Jka antisera and officially meet the standard. I groaned when I saw they revised the standard because, at first glance, I thought we would have to QC the antigen we were trying to rule
  3. My hospital is not AABB but I will put in my 2 cents for what it is worth. The way I read this: The collecting/pooling facility will put a DIN on the product. The receiving facility will not change, alter, or remove the number (on that bag). Reading between the lines if you take those units and combine them in a different way with a NEW number, in a new bag, you are not altering the numbers on the original bags. You have a new bag with a new number and the next facility (should there be one) should not change your new number. Your computer system should be able to retain the original prod
  4. I am also interested in how others are checking the Platelet incubator. Our probes are incased in some metal protective shield that makes them very difficult to get to. There are only some little nubs sort of sticking out about an inch or so.
  5. Our hospital system pays a Cerner subcontract team to validate the big upgrades. I am SO GRATEFUL for this!!!!!. It would be overwhleming for one person to have to go thru everything associated with BB. We get a huge notebook for our records of what the did. We still have to test a few things. For small upgrades that affect BB, I perform some type of testing with screen shots during testing and also after it goes in. These are usually not too much. I always test the electronic crossmatch after every validation so I have it on record so I won't get dinged by an inspector.
  6. We used to just document on the maintenance form and review at the end of the month. Then I read somewhere, it may have been on this site, that the software to read the backup disks on the Echo was proprietary and you must have their software to read the DVD backup disks. Our instrument was getting some age on it and I wasn't sure if we would remain with Immucor when we replaced it. So, I talked to Immucor and they said it could be read on Notepad even without the Echo computer. I tried reading it on my computer and it doesn't look anything like it does on the instrument. I sort of figured it
  7. Our QC was minimal several years ago based on the fact that the first ABO back type would confirm the antisera. The standard says the Anti-IgG reactivity is checked during crossmatching. I think our QC only had about 6 tubes and 1 gel card. Very minimal! But I started thinking that we didn't actually have proof the AHG worked on a particular day. (If it isn't documented you didn't do it) I thought proof needed to be added or some tech working that day would need to remember to mark the form hours later. I knew this would get missed multiple times in a year so I added these to the QC form. I e
  8. We have a dry erase board in an area that can be seen by all techs where we write general transient info such as 3 PLT ordered, # of available PLT, reserved PLT for heart surgery, etc. This info is erased as it is updated. Most of our issues seem to center around PLT. LOL I have a clipboard with basically a sheet with instructions on the top and basically lines and cues about date/time on the rest of the sheet. If we talk to a physician, nurse or blood center about an issue, we write the info on the clipboard. Some problems take up most of the page so they take as much of the sheet as th
  9. Our hospital only did the minimum for years and was never sited. However, a few years ago it seems like the CAP standard changed to read that all reagents must be tested with positives and negatives. Or maybe I REALLY read the wording closely. So I redesigned my QC with pos and neg for all reagents. And we do check the A2 cells everyday. I know if I left that off, my people would forget to do QC on the rare occasion they actually needed to use the cells. I try to stay ahead of the issue. I will say, I was inspecting a hospital about 2 years ago and I asked the person in charge of the BB a
  10. I also called CAP in regarding this standard. It has been a while I was told we only had to compare kits such as the fetal screen kits. She said basically if there were positive and negative controls in a kit, we had to compare new with old. We did not have to compare elu-kits because there are no controls with the kit and all reagents used to test the eluate have been QC'd that day. I also heard this on a CAP webinar about the most common deficiencies a year or two ago. With regards to rare and not so rare antisera, we did not have to compare these at all because we do QC on day o
  11. You do not need to register with the FDA if you are just pooling, thawing, changing FFP to Thawed Plasma or splitting units like for pediatric use. The end product is basically the same as the beginning product. However, if you take a product and make a new product then you would need to register with FDA. An example would be combining RBC with FFP to make whole blood for an exchange transfusion. The end product is different from the starting product. I found a good explanation for this on the AABB site. 2012 ASK THE FDA and CLIA Transcript question #29. You can access and print thes
  12. We use the J series for antigen typing. The way I read it, the J series includes antigen typing and it is an CAP approved PT since they make it. They probably would like us to order the RCBCAT since all their PT are pricey but I think "J" meets the letter of the standard. We will be inspected in the sprig, I will see if I get called out on this.
  13. Remember, you have to follow it to a "T" if stringent rules are written in a policy. You can be dinged for not following your policy. I would be a bit vague when writing the policy with a lot of wiggle room: wash hands after removing gloves or when leaving area, no lab coats outside of lab area, no eating or drinking or applying makeup, etc. All of our area is considered dirty, including phones, community pens, benches, door knobs and refrigerator handles. We couldn't swing a clean area and a dirty area here since everything is in one room with phones and computers scattered around. All i
  14. I am on the trauma committee where I brought up the idea of using A plasma instead of AB several years ago. The head Trauma physician was there and thought it was a great idea. He just wants plasma when he needs it. I approached our Medical Lab Director and had to provide him with documentation I found from Mayo so he felt better about it. Unfortunately, my pathologist limits us to only 2 until we have a confirmed blood type. I pushed for 4 but couldn't change his mind. I wrote up my policies and was done with it. I did not bring this up to nursing We keep 2 A thawed at all times. We rota
  15. I just answered this question. My Score PASS  
×
×
  • Create New...

Important Information

We have placed cookies on your device to help make this website better. You can adjust your cookie settings, otherwise we'll assume you're okay to continue.